Inhibitory Effects of Several Korean Traditional Herbs on Anaphylactic Reaction and Mast Cell Activation
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Korean traditional herbs, especially Anemarrhena asphodeloides (A. asphodeloides), Salvia miltiorrhiza (S. miltiorrhiza),and Terminalia chebula (T. chebula) have been known to have the immunomodulatory, anti-tumor, and anti-inflammatory effects. However, direct cellular mechanism underlying the mast cell-mediated anaphylaxis-like reaction has poorly been understood. In the present study, the effects of the methanol extracts of A. asphodeloides (MEAA), S. miltiorrhiza (MESM), and T. chebula (METC) on anaphylactic reaction were investigated. Using in vitro and in vivo experiments, the influences of MEAA, MESM, and METC on the compound 48/80-induced anaphylaxis-like reaction and mast cell activation, and IgEmediated PCA were examined. Results are below; 1) MEAA, MESM, and METC significantly inhibited systemic anaphylaxis-like reaction, ear swelling response, and IgE-mediated PCA. 2) the compound 48/80-induced mast cell degranulation, histamine release of rat peritoneal mast cells (RPMC) were significantly inhibited by the pretreatment with MEAA, MESM, and METC, and 3)the compound 48/80-induced calcium influx in RPMC was significantly inhibited by the pretreatment with MEAA,MESM, and METC. These results suggest that MEAA, MESM, and METC may be an activity to inhibit the compound 48/80-induced or anti-DNP IgE-mediated anaphylactic reactions by blocking histamine release and calcium uptake into RPMC. MEAA,MESM, and METC potentially may serve as an effective therapeutic tool for allergic diseases.
Abstract
Korean traditional herbs, especially Anemarrhena asphodeloides (A. asphodeloides), Salvia miltiorrhiza (S. miltiorrhiza),and Terminalia chebula (T. chebula) have been known to have the immunomodulatory, anti-tumor, and anti-inflammatory effects. However, direct cellular mechanism underlying the mast cell-mediated anaphylaxis-like reaction has poorly been understood. In the present study, the effects of the methanol extracts of A. asphodeloides (MEAA), S. miltiorrhiza (MESM), and T. chebula (METC) on anaphylactic reaction were investigated. Using in vitro and in vivo experiments, the influences of MEAA, MESM, and METC on the compound 48/80-induced anaphylaxis-like reaction and mast cell activation, and IgEmediated PCA were examined. Results are below; 1) MEAA, MESM, and METC significantly inhibited systemic anaphylaxis-like reaction, ear swelling response, and IgE-mediated PCA. 2) the compound 48/80-induced mast cell degranulation, histamine release of rat peritoneal mast cells (RPMC) were significantly inhibited by the pretreatment with MEAA, MESM, and METC, and 3)the compound 48/80-induced calcium influx in RPMC was significantly inhibited by the pretreatment with MEAA,MESM, and METC. These results suggest that MEAA, MESM, and METC may be an activity to inhibit the compound 48/80-induced or anti-DNP IgE-mediated anaphylactic reactions by blocking histamine release and calcium uptake into RPMC. MEAA,MESM, and METC potentially may serve as an effective therapeutic tool for allergic diseases.
참고문헌 (32)
- Bradding P, "Novel approaches to the inhibition of mast cells in allergic disease", Clin Exp Allergy, 38, pp.704~708 (2008)
- Chai OH, "Inhibitory effects of Morus alba on compound 48", 80-induced anaphylactic reactions and anti-chicken gamma globulin IgE-mediated mast cell activation, 2005, pp.28, 1852~1858
- Chang JS, "Antileukemic activity of Bidens pilosa L. var. minor (Blume) Sherff and Houttuynia cordata Thunb", Am J Chin Med, 29, pp.303~312 (2001)
- Chiang LC, "Anti-Herpes simplex virus activity of Bidens pilosa and Houttuynia cordata", Am J Chin Med, 31, pp.355~362 (2003)
- Choi YH, "Inhibitory effects of Agaricus blzei on mast cell-mediated anaphylaxis-like reaction", Biol Pharm Bull, 29, pp.1366~1371 (2006)
- Choi YH, "Inhibitory effects of anaphylaxis-like reaction and mast cell activation by water extract from the fruiting body of Phellinus linteus", Biol Pharm Bull, 29, pp.1360~1365 (2006)
- D’Souza P, "Antioxidant properties of Aller-7, a novel polyherbal formulation for allergic rhinitis", Drugs Exp Clin Res, 30, pp.99~109 (2004)
- Fang ZY, "Tanshinone IIA down-regulates the CD40 expression and decreases MMP-2 activity on atherosclerosis induced by high fatty diet in rabbit", J Ethnopharmacol, 115, pp.217~222 (2008)
- Hachisuka H, "Effect of antianaphylactic agents on substance P induced histamine release from rat peritoneal mast cells", Arch Dermatol Res, 280, pp.158~162 (1988)
- Inagaki N, "Homologous passive cutaneous anaphylaxis in various strains of mice", Int Arch Allergy Appl Immunol, 81, pp.58~61 (1986)
- Inagaki N, "Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear", Int Arch Allergy Appl Immunol, 80, pp.285~290 (1986)
- Jang SI, "Tanshinone IIA inhibits LPS-induced NF-kappa B activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1", 2, p38 and JNK pathways, 2006, pp.542, 1~7
- Jeong HJ, "Inhibition of TNF-alpha and IL-6 production by Aucubin through blockade of NF-kappa B activation RBL- 2H3 mast cells", Cytokine, 18, pp.252~259 (2002)
- Klemm S, "Inflammatory signal transduction from the FcεRI to NF-κB", Immunol, 211, pp.815~820 (2006)
- Lantz CS, "Role for interleukin-3 in mastcell and basophil development and in immunity to parasites", Nature, 392, pp.90~93 (1998)
- Lee B, "Mangiferin inhibits passive cutaneous anaphylaxis reaction and pruritus in mice", Planta Med, 75, pp.1415~1417 (2009)
- Lee B, "Inhibitory effects of steroidal timosaponins isolated from the rhizomes of Anemarrhena asphodeloides against passive cutaneous anaphylaxis reaction and pruritus", Immunopharmacol Immunotoxicol, 32, pp.357~363 (2010)
- Li C, "Observations of the curative effect with various liquid for post operative irrigation of ESS of treating chronic sinusitis and nasal polyps", Lin Chuang Er Bi Yan Hou Ke Za Zhi, 15, pp.53~54 (2001)
- Li GZ, "Inhibitory effects of Houttuynia cordata water extracts on anaphylactic reaction and mast cell activation", Biol Pharm Bull, 28, pp.1864~1868 (2005)
- Guang Zhao Li, "Inhibitory effects of epigallocatechin gallate on compound 48", 80-induced mast cell activation and passive cutaneous anaphylaxis, 2005, pp.37(4), 290~296[DOI]
- Lorenz D, "Mechanism of peptide-induced mast cell degranulation. Translocation and patch-clamp studies", J Gen Physiol, 112, pp.577~591 (1998)
- Mahesh R, "Effect of Terminalia chebula aqueous extract on oxidative stress and antioxidant status in the liver and kidney of young and aged rats", Cell Biochem Funct, 27, pp.358~363 (2009)
- Mascotti K, "HPC viability measurement: trypan blue versus acridine orange and propidium iodide", Transfusion, 40, pp.693~696 (2000)
- Mekori YA, "Mast cells in innate immunity", Immunol Rev, 173, pp.131~140 (2000)
- 나영천, "피부신경펩티드에 의한 비만세포 활성화에 대한 연구", Anatomy and Cell Biology, 42(3), pp.197~207 (2009), 대한해부학회
- Pratibha N, "Anti-inflammatory activities of Aller-7, a novel polyherbal formulation for allergic rhinitis", Int J Tissue React, 26, pp.43~51 (2004)
- Puxeddu I, "Mast cells and eosinophils: A novel link between inflammation and angiogenesis in allergic diseases", J Allergy Clin Immunol, 116, pp.531~536 (2005)
- Suguna L, "Influence of Terminalia chebula on dermal wound healing in rats", Phytother Res, 16, pp.227~231 (2002)
- Tanaka S, "Ca2+ influx-mediated histamine synthesis and IL-6 release in mast cells activated by monomeric IgE", Eur J Immunol, 35, pp.460~468 (2005)
- Trinh HT, "Tanshinones isolated from the rhizome of Salvia miltiorrhiza inhibit passive cutaneous anaphylaxis reaction in mice", J Ethnopharmacol, 132, pp.344~348 (2010)
- Yeum HS, "Fritillaria cirrhosa, Anemarrhena asphodeloids, Lee-Mo-Tang and cyclosporine a inhibit ovalbumin-induced eosinophil accumulation and Th2-mediated bronchial hyperresponsiveness in a murine model of asthma", Basic Clin Pharmacol, 100, pp.205~213 (2007)
- Yoshimura T, "Increased in vitro release of interferon-gamma from ampicillin-stimulated peripheral blood mononuclear cells in Stevens-Johnson syndrome", Biol Pharm Bull, 27, pp.929~931 (2004)